Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic MSC Implantation for Degenerative Disc Disease
NCT04499105Phase 2Unknown
- Start
- Jul 2017
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogenic mesenchymal stem cells in degenerative disc disease (DDD). Status: unknown.
02
Drugs
allogenic mesenchymal stem cells
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT04499105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04499105.